PITTSBURGH, April 9 /PRNewswire/ -- ChemImage Corporation announced today the receipt of its 100th U.S. patent, number 7,692,776 for a chemical imaging explosives optical sensor that detects explosive compounds.
Over the past 16 years, ChemImage has invested substantial resources in building a robust patent portfolio which includes patents for chemical imaging instrumentation, image analysis, threat detection, forensics tools, pharmaceutical analysis, particle sizing, and biomedical diagnostics.
“Issuance of our 100th patent represents a significant milestone in ChemImage’s development,” said Dr. Patrick Treado, ChemImage Founder and Chief Technology Officer. “As a technology company that is addressing critical measurement needs across a variety of industries, we have secured substantial protection of our intellectual property that will assist in fostering partnerships with market leaders worldwide.”
ChemImage Corporation, a leader in Chemical Imaging technology, provides instrumentation, software and expert consulting to government, industrial and academic organizations for numerous applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research. The company’s proprietary, state-of-the-art Chemical Imaging technology can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters is located in Pittsburgh, Pennsylvania, where it houses research and development laboratories, as well as engineering and manufacturing facilities. For more information, contact ChemImage at +1 412-241-7335 or visit www.chemimage.com.
Suzanne Cibotti
Sr. Marketing Communications Specialist ChemImage Corporation 412.241.7335, ext. 291 cibottis@chemimage.com
This release was issued through WebWire(R). For more information visit http://www.webwire.com. SOURCE ChemImage Corporation Back to top RELATED LINKS http://www.chemimage.com
